Cel-Sci regulatory update

Cel-Sci Corp. (CELI) CELI has been allowed a Japanese patent covering the production of a serum-free and mitogen-free interleukin-1 (IL-1) preparation. The IL-1 cytokine is involved in rheumatiod art...